For cancer types not included in our BRCA1/2-associated FCH criteria, the most common malignancies were gastric, colorectal, and lung cancers, observed in 49 (10.3%), 30 (6.3%), and 28 (5.9%) patients, respectively. This evidence concerns the gene BRCA1 and lung cancer.